MedPath

Shionogi, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.shionogi.com

Clinical Trials

34

Active:32
Completed:0

Trial Phases

3 Phases

Phase 1:15
Phase 2:1
Phase 3:1

Drug Approvals

6

FDA:6

Drug Approvals

Methylin

Approval Date
Jun 15, 2023
FDA

Osphena

Approval Date
Mar 16, 2023
FDA

Fetroja

Approval Date
Nov 19, 2021
FDA

Mulpleta

Approval Date
Oct 29, 2020
FDA

FORTAMET

Approval Date
Nov 30, 2018
FDA

Naprelan

Approval Date
Aug 22, 2013
FDA

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Phase 1
15 (88.2%)
Phase 2
1 (5.9%)
Phase 3
1 (5.9%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.